dimethyl fumarate "hexal" 240 mg enterokapsler, hårde
hexal a/s - dimethylfumarat - enterokapsler, hårde - 240 mg
dimethyl fumarate "stada" 240 mg enterokapsler, hårde
stada arzneimittel ag - dimethylfumarat - enterokapsler, hårde - 240 mg
dimethyl fumarate "glenmark" 240 mg enterokapsler, hårde
glenmark arzneimittel gmbh - dimethylfumarat - enterokapsler, hårde - 240 mg
dimethyl fumarate "teva gmbh" 120 mg enterokapsler, hårde
teva gmbh - dimethylfumarat - enterokapsler, hårde - 120 mg
dimethyl fumarate "teva gmbh" 240 mg enterokapsler, hårde
teva gmbh - dimethylfumarat - enterokapsler, hårde - 240 mg
dimethylfumarat "pharmathen" 120 mg enterokapsler, hårde
pharmathen s.a. - dimethylfumarat - enterokapsler, hårde - 120 mg
dimethylfumarat "pharmathen" 240 mg enterokapsler, hårde
pharmathen s.a. - dimethylfumarat - enterokapsler, hårde - 240 mg
skilarence
almirall s.a - dimethylfumarat - psoriasis - immunosuppressiva - skilarence er indiceret til behandling af moderat til svær plaque psoriasis hos voksne brug for systemisk medicinsk terapi.
tecfidera
biogen netherlands b.v. - dimethylfumarat - multipel sclerose - immunosuppressiva - tecfidera is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
vumerity
biogen netherlands b.v. - diroximel fumarate (biib098) - multipel sklerose, recidiverende-remitterende - immunosuppressiva - vumerity is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (see section 5. 1 for important information on the populations for which efficacy has been established).